Urologic Neoplasms

Urologic neoplasms are abnormal growths of tissue, that can be benign or malignant. They can occur in different organs and tissues of the urologic system. Some types of these neoplasms can be present in both men and women, such as in the case of the bladder and the kidney, and others are genders specific, such as testicular neoplasms for men and vaginal neoplasms for women.

Showing 1–12 of 15 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price
Nivolumab 8006657	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	08/2024	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAN6970	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	08/2018	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAP6351	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	10/2018	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAQ3795	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	02/2018	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAU3964	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	05/2019	390,00 €	view product Max: 10 Min: 1 Step: 1
Nivolumab AAW0883	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	01/2019	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAW6409	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	09/2020	338,00 €	view product Max: 8 Min: 1 Step: 1
Nivolumab AAX0742	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	11/2020	270,00 €	view product Max: 10 Min: 2 Step: 1
Nivolumab AAY2764	PD-1	Monoclonal Antibody	Opdivo®	10 mg/mL	–	2 mg	-80°C	02/2021	405,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 6302603D04	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	07/2018	794,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302601E01	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	12/2018	794,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302607002	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	03/2019	794,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab 7302613A05	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	07/2019	794,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab U001450	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	yes	2 mg	-80°C	04/2022	841,00 €	view product Max: 10 Min: 1 Step: 1
Pembrolizumab U029851	PD-1	Monoclonal Antibody	Keytruda®	25 mg/mL	–	2 mg	-80°C	11/2022	952,80 €	view product Max: 10 Min: 1 Step: 1

Not looking for Urologic Neoplasms?

Search our therapeutic molecules product database

Browse all drug aliquots in stock

Need support? Please contact us

Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin

+49 (0) 30 959 99 8831 info@evidentic.com

Urologic Neoplasms

Not looking for Urologic Neoplasms?

Search our therapeutic molecules product database

© All rights reserved

Evidentic – The reference drug company

we are recruiting